Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.92 USD | +12.20% | -43.21% | -55.12% |
Mar. 27 | Ampio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 26 | Top Midday Decliners | MT |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 1.71M |
---|---|---|---|---|---|
Net income 2022 | -16M | Net income 2023 | -8M | EV / Sales 2022 | - |
Net cash position 2022 | 11.88M | Net cash position 2023 | 3.82M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.15
x | P/E ratio 2023 |
-0.19
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.86% |
1 day | +12.20% | ||
1 week | -43.21% | ||
Current month | -40.65% | ||
1 month | -50.00% | ||
3 months | -58.18% | ||
6 months | -74.93% | ||
Current year | -55.12% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Daniel Stokely
DFI | Director of Finance/CFO | 60 | 19-07-30 |
Howard Levy
CTO | Chief Tech/Sci/R&D Officer | 70 | 21-10-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Stevens
BRD | Director/Board Member | 75 | 11-05-31 |
J. Buchi
CHM | Chairman | 69 | 21-10-12 |
Michael Martino
CEO | Chief Executive Officer | 68 | 21-10-12 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.92 | +12.20% | 53,291 |
24-03-27 | 0.82 | +1.05% | 101,997 |
24-03-26 | 0.8115 | -51.70% | 327,534 |
24-03-25 | 1.68 | +0.60% | 91,877 |
24-03-22 | 1.67 | -1.76% | 279,866 |
Delayed Quote Nyse, March 28, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-55.12% | 682K | |
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |